See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: June 12, 2007

Psoriasis and Psoriatic Disorders Diabetes Mellitus, Type 2 Allergy (Pediatric)

(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:

Psoriasis and Psoriatic Disorders

You may be eligible to participate in this study of psoriasis if you are 18 or older, have symptomatic red scaly patches of skin, and can visit the clinic office six times in approximately eight weeks. Participants will receive free skin exams, study drug or placebo, and up to $175.00 for participation.

The research site is in Edison, NJ.

More information

Please see http://www.centerwatch.com/patient/studies/cat126.html.

-----

Diabetes Mellitus, Type 2

This study will evaluate the safety and effectiveness of an investigational diabetes medication that will be administered once weekly, once every two weeks, or once every four weeks. Participants will receive study related medical evaluations and study medication at no cost, and may be eligible for time and travel compensation. Participants must be ages 18 to 75 and diagnosed with type 2 diabetes. Additional criteria apply.

The research site is in San Antonio, Texas.

More information

Please see http://www.centerwatch.com/patient/studies/cat603.html.

-----

Allergy (Pediatric)

Boys ages 3 to 9 and girls ages 3 to 8 may be eligible for this study of an investigational nasal spray for perennial allergic runny nose. Compensation is available to those who qualify. Additional criteria apply.

The research site is in Dallas, Texas.

More information

Please see http://www.centerwatch.com/patient/studies/cat432.html.

-----

Copyright 2007 Thomson CenterWatch. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.